medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2014, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2014; 30 (1)

Nomenclature evolution for factors of human leukocyte antigen system

Chang MA, Bencomo HAA, Morera BLM, Ustáriz GC, de la Guardia PO

Language: Spanish
References: 32
Page: 11-20
PDF size: 55.21 Kb.


ABSTRACT

The nomenclature for the Human Leukocyte Antigen (HLA) system has been modified as its factors were been discovered and characterized. The progress in the molecular biology field led the most important nominal changes in the so call Major Histocompatibility Complex (MHC). At present, an allele name is formed by the prefix "HLA" followed by a hyphen (-) and the name of the gene A, B, C, DP, DQ or DR. After the lead an asterisk (*) is used as a separator and it is followed by four numeric fields delimited each other by two colons (:). The first field describes the allele group and frequently corresponds with the serology name, and the second field indicates the specific protein. The third field shows a synonymous nucleotide substitution; the fourth one shows differences in a non-coding region. Suffixes could be used to denote changes in the antigen expression: "N" for null, "L" for "low", "S" for secreted without membrane expression, "C" for cytoplasmatic, "A" for aberrant, when doubts in the expression; and "Q" for questionable, in case of mutations that could affect the normal expression levels.


REFERENCES

  1. Klein J. George Snell's first foray into the unexplored territory of the major histocompatibility complex. Genetics. 2001 Oct;159(2):435-9.

  2. Mahdi BM. A glow of HLA typing in organ transplantation. ClinTransl Med. 2013 Feb;2(1):6. doi:10.1186/2001-1326-2-6.

  3. Ryan SO, Cobb BA. Roles for major histocompatibility complex glycosylation in immune function. Semin Immunopathol. 2012 May;34(3):425-41.

  4. Panter MS, Jain A, Leonhardt RM, Ha T, Cresswell P. Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex. J Biol Chem. 2012 Sep;287(37):31172-84.

  5. Varney MD, Castley AS, Haimila K, Saavalainen P. Methods for diagnostic HLA typing in disease association and drug hypersensitivity. Methods Mol Biol. 2012;882:27-46.

  6. Guarene M, Capittini C, De Silvestri A, Pasi A, Badulli C, Sbarsi I, et al. Targeting the Immunogenetic Diseases with the Appropriate HLA Molecular Typing: Critical Appraisal on 2666 Patients Typed in One Single Centre. Biomed Res Int. 2013;2013:904247. doi:10.1155/2013/904247.

  7. Erlich H. HLA DNA typing: past, present, and future. Tissue Antigens. 2012 Jul;80(1):1-11.

  8. Tait BD. The ever-expanding list of HLA alleles: changing HLA nomenclature and its relevance to clinical transplantation. Transplant Rev (Orlando). 2010 Jan;25(1):1-8.

  9. Kanda Y, Kanda J, Atsuta Y, Maeda Y, Ichinohe T, Ohashi K, et al. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation. Br J Haematol. 2013 May;161(4):566-77.

  10. Abbas AK, Lichtman AH, Pillai S. Major Histocompatibility Complex Molecules and Antigen Presentation to T Lymphocytes. Cellular and Molecular Immunology. 7th ed. Philadelphia: Elsevier/Saunders; 2010. p. 109-38.

  11. Raju TN. The Nobel chronicles. 1980: George Davis Snell (1903-96); Jean Baptiste Dausset (b 1916); Baruj Benacerraf (b 1920). Lancet. 1999 Nov 13;354(9191):1738.

  12. Staats J. Bibliography of George D. Snell. Transplant Proc. 1970 Mar;2(1):174-8.

  13. Russell ES. A history of mouse genetics. Annu Rev Genet. 1985;19:1-28.

  14. Paigen K. One hundred years of mouse genetics: an intellectual history. I. The classical period (1902-1980). Genetics. 2003 Jan;163(1):1-7.

  15. Talmage DW. Historia de la inmunología. In: Stites DP, Terr AI, Parslow TG, editors. Inmunología Básica y Clínica. 9na ed. México, D.F.: El Manual Moderno; 1998. p. XVII-XXIV.

  16. Kusnierczyk P. Better late than never: discovery of MHC restriction awarded with the Nobel Prize after 22 years (Nobel Prize for physiology or medicine in 1996). Postepy Biochem. 1997;43(2):66-72.

  17. Ada G. Twenty years into the saga of MHC-restriction. Immunol Cell Biol. 1994 Dec;72(6):447-54.

  18. Abbas AK, Lichtman AH, Pillai S. Complejo Principal de Histocompatibilidad. Inmnología Celular y Molecular. 6th ed. Barcelona: Elsevier/Saunders; 2009. p. 97-112.

  19. Albert E, Amos DB, Bodmer WF, Ceppellini R, Dausset J, Kissmeyer-Nielsen F, et al. Nomenclature for factors of the HLA system-1977. Transplantation. 1978 May;25(5):272-5.

  20. Paigen K. One hundred years of mouse genetics: an intellectual history. II. The molecular revolution (1981-2002). Genetics. 2003 Apr;163(4):1227-35.

  21. de Groot NG, Otting N, Robinson J, Blancher A, Lafont BA, Marsh SG, et al. Nomenclature report on the major histocompatibility complex genes and alleles of Great Ape, Old and New World monkey species. Immunogenetics. 2012 Aug;64(8):615-31.

  22. Nomenclature for factors of the HLA system. Bull World Health Organ. 1975;52(3):261-5.

  23. Marsh SG, WHO Nomenclature Committee for Factors of the HLA System. Nomenclature for factors of the HLA system, update June 2013. Hum Immunol. 2013 Jul 20. pii: S0198-8859(13)00206-1. doi:10.1016/j.humimm.2013.07.005.

  24. New nomenclature for the HLA system. J Immunol. 1976 Feb;116(2):573-4.

  25. Nomenclature for factors of the HLA system, 1987. Tissue Antigens. 1988 Oct;32(4):177-87.

  26. Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010 Apr;75(4):291-455.

  27. Bodmer WF. HLA: what's in a name? A commentary on HLA nomenclature development over the years.Tissue Antigens. 1997 Mar;49(3 Pt 2):293-6.

  28. McCluskey J, Kanaan C, Diviney M. Nomenclature and serology of HLA class I and class II alleles. Curr Protoc Immunol. 2003 Feb;Appendix 1:Appendix 1S.

  29. Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, et al. Nomenclature for factors of the HLA system, 2002. Tissue Antigens. 2002 Nov;60(5):407-64.

  30. IMGT/HLA. Nomenclature for Factors of the HLA System. 2013 [Citado 2013]; Disponible en: http://hla.alleles.org/nomenclature/naming.html

  31. Robinson J, Halliwell JA, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/HLA database. Nucleic Acids Res. 2012 Jan;41(Database issue):D1222-7.

  32. Mack SJ, Hollenbach JA. Allele Name Translation Tool and Update Nomenclature: software tools for the automated translation of HLA allele names between successive nomenclatures. Tissue Antigens. 2010 May;75(5):457-61.




2020     |     www.medigraphic.com